Previous Issue - Issue 44
Issue 44 | 2021
- Foreword
- Strategy
- Research & Development
- Manufacturing
- Information Technology
- Advertorials Go to Digital Magazine
Issue 44
PREVIOUS ISSUE
Strategy
Current Trends in Regulatory Outsourcing Models
Pharmaceutical companies of all sizes are increasingly outsourcing elements of the development process including regulatory affairs This helps them to access specific technical regulatory or geographic expertise to flexibly augment staffing levels without adding to headcount and to deliver key operational outputs enabling internal staff to focus on...
PRACTICE MAKES PERFECT
Adopting industry best practice requires three critical skills
Every life science company is eager to find and absorb industry best practices and for good reason In a business environment that is changing quickly no firm can afford to be left behind and relying on internal experience and lessons is too slow It is essential to imitate as well as to innovate
Research & Development
ARAGEN
A trusted partner
One of the biggest challenges confronting pharma and biotech companies globally is the everincreasing RD costs to bring new drugs into the market The regulatory approvals are also getting more stringent which stretches the overall time required for new launches
ClinPro RESEARCH EMPOWERING SOLUTIONS
Your CRO partner for effective Drug Development in India
ClinPro Research established in Feb is an ISO certified fullservice capability CRO headquartered in Mumbai India We cater to the clinical requirements of both domestic and international pharmaceutical companies biotech companies medical device companies ayurvedic and nutraceutical companies with our exceptional suite of solutions which includes e...
Manufacturing
Applying PAT to the Continuous Digital Biomanufacturing of Monoclonal Antibodies
Monoclonal antibodies mAbs are the highest selling class of biologics due to their specific action and reduced immunogenicity As the use of mAbs promotes treating many diseases eg cancer with better targeted immunological approaches the development of mAbs will continue to increase
